VitaSpring Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 11, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Market Capitalization	2	52	31	3,105	3,083	2,891
Market Cap Growth	-	66.73%	-99.00%	0.72%	6.64%	296.72%
Enterprise Value	2	52	31	3,106	3,084	2,892
Last Close Price	0.01	0.25	0.15	15.00	14.93	14.00
PE Ratio	-	-	-	-	-	3178.77
PS Ratio	-	-	-	-	-	515.09
PB Ratio	-0.51	-11.69	-7.73	-926.95	-1286.61	1832.78
P/TBV Ratio	-	-	-	-	-	1832.78
EV/Sales Ratio	-	-	-	-	-	515.14
EV/EBITDA Ratio	-	-	-	-	-	2547.59
EV/EBIT Ratio	-	-	-	-	-	2566.49
Debt / Equity Ratio	-	-	-	-0.03	-0.11	0.29
Debt / EBITDA Ratio	-	-	-	-	-	0.38
Net Debt / Equity Ratio	0.00	0	0	-0.02	-0.10	0.23
Net Debt / EBITDA Ratio	0.02	0.01	0	-0.06	-0.06	0.31
Net Debt / FCF Ratio	-1.95	0.78	0.02	-2.00	-3.01	-1.04
Asset Turnover	-	-	-	-	-	2.96
Quick Ratio	0.00	0	0	0.01	0.13	1.76
Current Ratio	0.00	0.00	0	0.01	0.14	1.76
Return on Equity (ROE)	-	-	-	-	-	108.68%
Return on Assets (ROA)	-2096.65%	-1655.78%	-560.17%	-153.34%	-119.50%	37.13%
Return on Invested Capital (ROIC)	-	-	-	-	-	91.65%
Return on Capital Employed (ROCE)	8.70%	8.70%	16.90%	33.10%	181.40%	60.40%
Earnings Yield	-17.87%	-0.80%	-2.50%	-0.04%	-0.14%	0.03%
FCF Yield	-	-0.01%	-0.05%	-0.00%	-0.00%	-0.01%
Buyback Yield / Dilution	-	-	-	-0.25%	-0.26%	-126.13%